GGrantIndex
Sort

50,496 grants matching lung cancer

Bayesian machine learning for complex missing data and causal inference with a focus on cardiovascular and obesity studies

$465,349
Michael J Daniels · University Of Florida · R01 · FY2024 · HL

Placental Senescence in Peripartum Cardiomyopathy

$465,334
Jason David Roh · Massachusetts General Hospital · R01 · FY2025 · HL

Occupational and Environmental Determinants of Cancer among Women and Minorities

$465,271
Jonathan Hofmann · Division Of Cancer Epidemiology And Genetics · ZIA · FY2021 · CA

Regulatory roles of variable mechanical stimuli in cell function

$465,252
Bela Suki · Boston University (Charles River Campus) · R01 · FY2012 · HL

Preclinical Time domain Fluorescence Tomography Platform

$465,244
Anand T.n. Kumar · Massachusetts General Hospital · R01 · FY2019 · CA

IMAGING AND EXOSOMAL GENOMICS AS AN EARLY IDENTIFIER OF LUNG CANCER

$465,232
The Leland Stanford Junior University · · FY2020 · Defense Health Agency

Translating phospholipase activatable fluorophores for the sensitive detection of non-small cell lung cancer

$465,189
Edward J Delikatny · University Of Pennsylvania · R01 · FY2024 · CA

Translational Studies on Electronic Cigarette-derived Oxidants and their Long-term Pulmonary Effects

$465,187
John P Richie · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2021 · HL

Assessing the Impact of State Preemption Laws

$465,177
Sunday Azagba · Pennsylvania State University, The · R01 · FY2024 · CA

Psychiatry Consultation Liaison Service Research

$465,176
Maryland Pao · National Institute Of Mental Health · ZIA · FY2013 · MH

NF-kB Regulation of the Muscle Microenvironment in Cancer Cachexia

$465,055
Denis C Guttridge · Medical University Of South Carolina · R01 · FY2021 · AR

Mortality and renal-disease among lead-exposed workers

$465,028
Nelson K Steenland · Emory University · R01 · FY2016 · OH

A Novel Plasminogen Receptor in Breast Cancer

$464,971
Barbara M Mueller · Torrey Pines Inst For Molecular Studies · R01 · FY2012 · CA

RNA DEGRADATION ENZYMES: NOVEL TARGETS IN NON-SMALL CELL LUNG CANCER

$464,956
Yale Univ · · FY2020 · Defense Health Agency

Biomechanics of Blood Stream Infections

$464,913
John G Younger · University Of Michigan At Ann Arbor · R01 · FY2009 · GM

Mechanism of Intratumoral Transport of Particulate Drugs

$464,910
Haifa Shen · Methodist Hospital Research Institute · R01 · FY2020 · CA

Integrated 3D Xray and Dynamic Tomographic Optical Breast Imaging System

$464,903
David A Boas · Massachusetts General Hospital · R01 · FY2014 · CA

Deguelin in therapy of triple negative breast cancer

$464,897
Rajendra G Mehta · Iit Research Institute · R01 · FY2011 · CA

Mechanisms of Metastasis and Evasion of TGF-Beta Tumor Suppression Breast Cancer

$464,871
Joan Massague · Sloan-Kettering Inst Can Research · P01 · FY2010 · CA

Prospective validation of a multi-marker prostate cancer prediction model

$464,784
Hans Gã–sta Lilja · Sloan-Kettering Inst Can Research · R01 · FY2015 · CA

Targeting NSD1 in leukemia

$464,783
Tomasz Cierpicki · University Of Michigan At Ann Arbor · R01 · FY2021 · CA

Tumor maintenance and development in mouse models

$464,773
Harold E Varmus · Sloan-Kettering Inst Can Research · U01 · FY2008 · CA

Individually-tailored clinical decision support for management of indeterminate pulmonary nodules

$464,766
Alex Bui · University Of California Los Angeles · R01 · FY2019 · CA

Individually-tailored clinical decision support for management of indeterminate pulmonary nodules

$464,766
Alex Bui · University Of California Los Angeles · R01 · FY2021 · CA

TRIM37 is a genetic determinant of racial disparity in metastatic TNBC patients

$464,680
Sanchita Bhatnagar · University Of California At Davis · R01 · FY2022 · CA